Logo Logo
Switch Language to German

Hatscher, Lukas; Lehmann, Christian H. K.; Purbojo, Ariawan; Onderka, Constantin; Liang, Chunguang; Hartmann, Arndt; Cesnjevar, Robert; Bruns, Heiko; Gross, Olaf; Nimmerjahn, Falk; Ivanovic-Burmazovic, Ivana; Kunz, Meik; Heger, Lukas and Dudziak, Diana (2021): Select hyperactivating NLRP3 ligands enhance the T(H)1-and T(H)17-inducing potential of human type 2 conventional dendritic cells. In: Science Signaling, Vol. 14, No. 680, eabe1757

Full text not available from 'Open Access LMU'.


The detection of microorganisms and danger signals by pattern recognition receptors on dendritic cells (DCs) and the consequent formation of inflammasomes are pivotal for initiating protective immune responses. Although the activation of inflammasomes leading to secretion of the cytokine IL-1 beta is typically accompanied by pyroptosis (an inflammatory form of lytic programmed cell death), some cells can survive and exist in a state of hyperactivation. Here, we found that the conventional type 2 DC (cDC2) subset is the major human DC subset that is transcriptionally and functionally poised for inflammasome formation and response without pyroptosis. When cDC2 were stimulated with ligands that relatively weakly activated the inflammasome, the cells did not enter pyroptosis but instead secreted IL-12 family cytokines and IL-1 beta. These cytokines induced prominent T helper type 1 (T(H)1) and T(H)17 responses that were superior to those seen in response to Toll-like receptor (TLR) stimulation alone or to stronger, classical inflammasome ligands. These findings not only define the human cDC2 subpopulation as a prime target for the treatment of inflammasome-dependent inflammatory diseases but may also inform new approaches for adjuvant and vaccine development.

Actions (login required)

View Item View Item